Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same.
Walsh
T J
TJ
Hiemenz
J
J
Pizzo
P A
PA
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007155:Immunologic Factors / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000009:adverse effects; D017708:Leukocyte Transfusion; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000145:classification / Q000150:complications* / Q000517:prevention & control; D012307:Risk Factors; D015163:Superinfection; D015996:Survival Rate
D000305:Adrenal Cortex Hormones; D000903:Antibiotics, Antineoplastic; D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors